About: Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1997 (uk) article scientifique publié en 1997 (fr) im Mai 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1997 (ast) scientific article published on 01 May 1997 (en)
publication date	wds:Q73304525-D0589F7A-9B8A-4B6D-9483-DB97597F2A87
publication date	1997-05-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73304525-028C7FDA-C7D3-44D8-BC39-17E851973C6B wds:Q73304525-04357F8D-BC85-4684-9619-21F108C977A4 wds:Q73304525-0F59CD18-1DA1-4D73-9452-D20CB1FD20A5 wds:Q73304525-18A2B27C-C074-43E8-A138-91E69D61497E wds:Q73304525-1BCA8906-71E9-4F20-8CD2-4FCB889140F2 wds:Q73304525-21F8DCA6-400A-421E-AFE9-5E36D78130FB wds:Q73304525-246A9690-890B-4B60-B827-720E04C736FC wds:Q73304525-29ABBC43-9714-410D-A4FB-7E0732E17230 wds:Q73304525-39613AF4-81B9-4DFE-8CF0-F15D0AE89F4E wds:Q73304525-39D31944-0D25-46E4-B74D-5236CB1B502B wds:Q73304525-414FC687-3411-4EBB-8941-7F9D68C73891 wds:Q73304525-4EF36BE0-306D-458F-AF66-20BE1F3746E7 wds:Q73304525-5BF91D18-5AE1-42A0-8ECD-29AF359AF015 wds:Q73304525-6E2743C5-9B23-4DA5-85F1-46CBC6DFA58C wds:Q73304525-6EF53205-84FA-4E3F-8CCD-57156B228B87 wds:Q73304525-942B1627-67B2-42F0-8264-F4364F8045E2 wds:Q73304525-977B4599-BB85-4B13-BD0F-FF03C6645385 wds:Q73304525-C1398C5E-1D64-4095-B5D9-2B3A52EA7B3D wds:Q73304525-D7487DC8-B9CC-4569-9E7B-669A2183BB21 wds:Q73304525-E1D2F47E-9AFC-4899-94A3-15BCD8153012
cites work	Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay Circadian variation in fibrinolytic activity in patients with variant angina Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina Colorimetry of angiotensin-I converting enzyme activity in serum Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1 Pharmacological studies on TA-6366, a new ACE inhibitor: II. Effect of long-term administration from the pre-hypertensive stage on blood pressure, relative heart weight and ACE activity of various tissues in spontaneously hypertensive rats (SHRs) Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterises a risk group among survivors of acute myocardial infarction
author name string	wds:Q73304525-4D4940DB-88BC-403D-8682-82A399AFAC8C wds:Q73304525-635478E6-D190-4B05-817F-5DEAB1913FDF wds:Q73304525-896E0912-C4B0-4A13-A207-68793C59D691 wds:Q73304525-C7521366-20A9-4BF2-985F-91D344B19FD7 wds:Q73304525-D1F184B9-34A3-4F11-B910-2D3863EE690F wds:Q73304525-FD7F06AD-3B02-4080-81B8-04F15C79AD83
author name string	H Ogawa H Yasue K Nishiyama H Soejima K Kaikita H Suefuji
rdfs:label	Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (en) Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (nl)
skos:prefLabel	Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (en) Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (nl)
name	Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (en) Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (nl)
title	wds:Q73304525-4203AE3D-50C9-44A8-B9A5-B205203AFAE1
title	Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction (en)
page(s)	wds:Q73304525-90A49EDD-A708-4BDF-BD91-A3DF423E2CBF
page(s)	441-445
instance of	wds:Q73304525-067CCE01-ABB3-40B6-B40A-0291028BE322
instance of	scholarly article
main subject	wds:Q73304525-920C2F6E-636F-4BE2-91D6-EC26903E30B8
main subject	myocardial infarction
PubMed ID	wds:Q73304525-354EEE55-20EE-42FD-B742-3CEE6F85C8C0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9134274
PubMed ID	9134274
published in	wds:Q73304525-48617042-FAF5-41F4-85BA-0976CC124294
published in	Clinical Cardiology
issue	wds:Q73304525-D27AA33E-7988-4295-ABCC-0A50A9F97525
volume	wds:Q73304525-13D48DD2-D406-4C52-A17E-EC80578EFB4B
issue	5
volume	20
DOI	wds:Q73304525-00FB16D7-2CC5-46C6-8F7F-1D78ACD79B2B
DOI	http://dx.doi.org/10.1002/CLC.4960200507
DOI	10.1002/CLC.4960200507
PMCID	wds:Q73304525-75BF9B93-78BE-4952-B44D-8D47B0453328
PMCID	6655695
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73304525
is cites work of	Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction? Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease Effect of imidapril and nifedipine on left ventricular hypertrophy in untreated hypertension. The Interface between Inflammation and Coagulation in Cardiovascular Disease Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure Angiotensin-converting enzyme inhibition and fibrinolytic balance Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software